Leukemia cell dissemination is one of the leading causes of cancer recurrence and patient death. Cancer progression occurs when cancerous T cells infiltrate or disseminate organs. T cells Acute lymphoblastic leukemiaInvasive cancer of immune cells in the blood has an overall survival rate of less than 25% for recurrent disease. Her study shows that a molecule called cyclin-dependent kinase 6 (CDK6) may be an important regulator of cancers such as leukemia. Wang’s research focuses on clarifying the relationship between cancer metabolism and cancer immunology. Understanding the complex biological communication between cancer cells and the patient’s healthy cells can help improve treatment options. , I have a lot of time to develop my research while growing my new lab, “she said. The R37 is more authoritative due to the time extension option. “I was thrilled when I learned that my grants were well received and the funding mechanism was converted to the more desirable R37. Wang, an assistant professor in the Department of Cellular and Molecular Pharmacology and Experimental Therapy, initially submitted a grant as a traditional R01 application. Was awarded a five-year, $ 344,000 annual grant by the National Cancer Institute (NCI) to pursue early researcher research on leukemia. Haizhen (Jen) Wang, Ph.D., researcher at the MUSC Hollings Cancer Center.

Game institute torrent